96 related articles for article (PubMed ID: 4130904)
41. [What is reliable in the therapy of hematologic diseases? II. Anemias, myeloproliferative diseases, panmyelopathy and agranulocytosis].
Sodomann CP; Malchow H; Schmidt M; Havemann K
Internist (Berl); 1970 Dec; 11(12):449-53. PubMed ID: 4924816
[No Abstract] [Full Text] [Related]
42. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
Wang JC; Chang TH; Goldberg A; Novetsky AD; Lichter S; Lipton J
Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
[TBL] [Abstract][Full Text] [Related]
43. [A case of acute myelomonocytic leukemia with myeloid metaplasia showing I. T. P. like symptoms in preleukemic stage (author's transl)].
Kita K; Fukuhara S; Shirakawa S; Uchino H; Ohta K; Adachi M; Tanaka S; Ito T
Rinsho Ketsueki; 1980 Aug; 21(8):1217-25. PubMed ID: 6934326
[No Abstract] [Full Text] [Related]
44. Extramedullary haematopoietic tumour of the breast: a case report in a woman with secondary myelofibrosis following essential thrombocythaemia.
Al-Nafussi A; Al-Okati D; Alsewan M
Histopathology; 2004 Jun; 44(6):625-6. PubMed ID: 15186279
[No Abstract] [Full Text] [Related]
45. [Primary myelofibrosis (osteomyelosclerosis). Current views on the pathogenesis, clinical course, diagnosis and therapy].
Demidova AV
Ter Arkh; 1974; 46(8):19-29. PubMed ID: 4422055
[No Abstract] [Full Text] [Related]
46. Myelofibrosis and myeloid tumors as a surgical disease.
French WE; Yates DR
South Med J; 1970 Apr; 63(4):387-91. PubMed ID: 5437585
[No Abstract] [Full Text] [Related]
47. [Extra-medullary megakaryocytes].
Oberling F; Cazenave JP; Waitz R
Nouv Rev Fr Hematol; 1973; 13(4):522-9. PubMed ID: 4271100
[No Abstract] [Full Text] [Related]
48. Myeloproliferative disorder therapy: assessment and management of adverse events--a cardiologist's perspective.
Kenny D
Hematol Oncol; 2009 Jun; 27 Suppl 1():8-10. PubMed ID: 19468985
[TBL] [Abstract][Full Text] [Related]
49. [Acute leukaemias with myelofibrosis. Clinical, cytohistological and evolutive aspects. Their place among malignant blood diseases with myelofibrosis (author's transl)].
Duhamel G; Stachowiak J; Deloux J; Lecomte D; de St Maur P; Najman A; Gorin N
Nouv Presse Med; 1981 Mar; 10(14):1119-23. PubMed ID: 7220283
[TBL] [Abstract][Full Text] [Related]
50. [Chromosome findings in myeloproliferative diseases].
Hellriegel KP
Internist (Berl); 1968 Dec; 9(12):465-70. PubMed ID: 4891471
[No Abstract] [Full Text] [Related]
51. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
Cortes J; Giles F; O'Brien S; Thomas D; Albitar M; Rios MB; Talpaz M; Garcia-Manero G; Faderl S; Letvak L; Salvado A; Kantarjian H
Cancer; 2003 Jun; 97(11):2760-6. PubMed ID: 12767088
[TBL] [Abstract][Full Text] [Related]
52. Distinct patterns of clonal evolution in patients with concurrent myelo- and lymphoproliferative neoplasms.
Kennedy JA; Medeiros JJF; Dobson SM; Arruda A; Sukhai MA; Stockley T; Tierens A; Minden MD; Kamel-Reid S; Dick JE; Gupta V
Blood; 2018 Nov; 132(20):2201-2205. PubMed ID: 30249785
[No Abstract] [Full Text] [Related]
53. Does auto-immunity contribute to anemia in myeloproliferative neoplasms (MPN)-associated myelofibrosis?
Barosi G; Magrini U; Gale RP
Leuk Res; 2010 Sep; 34(9):1119-20. PubMed ID: 20538336
[No Abstract] [Full Text] [Related]
54. Myelofibrosis and tuberculosis caused by atypical mycobacteria.
Arany LS; Sirridge MS
Dis Chest; 1968 Aug; 54(2):150-2. PubMed ID: 5665304
[No Abstract] [Full Text] [Related]
55. [Myelofibrosis probably secondary to splenic tuberculosis: report of a case (author's transl)].
Endo Y; Miura AB; Shibata A; Kakizaki G; Watanuki T
Rinsho Ketsueki; 1976 Dec; 17(12):1283-8. PubMed ID: 1035273
[No Abstract] [Full Text] [Related]
56. [An autopsied case of primary myelofibrosis with blastic proliferation terminating in ileus (author's transl)].
Yamaguchi H; Muto Y; Nishiyama S; Asai I; Tsukada T
Rinsho Ketsueki; 1975 Aug; 16(8):785-91. PubMed ID: 1237639
[No Abstract] [Full Text] [Related]
57. Current world literature.
Curr Opin Hematol; 2010 Mar; 17(2):139-53. PubMed ID: 20145442
[No Abstract] [Full Text] [Related]
58. Preface.
Verstovsek S
Best Pract Res Clin Haematol; 2014 Jun; 27(2):81-2. PubMed ID: 25189719
[No Abstract] [Full Text] [Related]
59. [A case of hemopoietic dysplasia accompanied with various prodromal symptoms (author's transl)].
Katsuki A; Kayawake S; Yoneda S; Hamami T; Nakata T; Nishio A; Hosoda M; Haruyama H; Sugishima K; Ijichi H; Isemura T
Rinsho Ketsueki; 1979 Dec; 20(12):1655-61. PubMed ID: 541851
[No Abstract] [Full Text] [Related]
60. [Therapeutic results of chronic leukemia and other myeloproliferative syndrome with streptonigrin in 92 cases (author's transl)].
Wang YL
Zhonghua Nei Ke Za Zhi; 1980 May; 19(3):223-5. PubMed ID: 7227060
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
